Data search


search
Exact
Search

Results for MligTC455_31429

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_31429 19 0.39 Mlig455_051457

Neo: -

Age: Up-Down-Down

Mlig455_051457 {REF} {Length: 7770} {Pfam: Pao retrotransposon peptidase [PF05380.15, score=49.1]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=33.9]} {Smed: dd_Smed_v6_34182_0_1, dd_Smed_v6_34182_0_1, [Score=88.2, Expect=6e-21]} {RNA1509_9219} {RNA1310_468} {RNA815_355.1}

Cumulative graph for MligTC455_31429

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 1.387 0.74 1.00000 1.00000
RegionR2 1.456 0.74 0.53499 0.90524
RegionR3 -1.149 0.74 1.00000 1.00000
RegionR4 -0.093 0.74 1.00000 1.00000
RegionR5 0.227 0.74 0.54951 0.91137
RegionR6 -1.353 0.74 1.00000 1.00000
RegionR7 -0.472 0.74 1.00000 1.00000
RegionR8 -0.003 0.74 1.00000 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -2.014 0.74 1.00000 1.00000
RegenerationR2 0.67 0.74 0.80639 0.99184
RegenerationR3 2.279 0.74 0.44035 0.82746
RegenerationR4 -0.023 0.74 0.67690 0.94451
RegenerationR5 0.987 0.74 0.70555 0.95364
RegenerationR6 1.739 0.74 0.54652 0.83693
RegenerationBL -0.81 0.74 1.00000 1.00000
RegenerationTP 3.136 0.74 0.44696 0.86538


Genes with expression patterns similar to MligTC455_31429

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_31429 19 0.39 Mlig455_051457

Neo: -

Age: Up-Down-Down

2 - - - - 1.000 1.000 Mlig455_051457 {REF} {Length: 7770} {Pfam: Pao retrotransposon peptidase [PF05380.15, score=49.1]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=33.9]} {Smed: dd_Smed_v6_34182_0_1, dd_Smed_v6_34182_0_1, [Score=88.2, Expect=6e-21]} {RNA1509_9219} {RNA1310_468} {RNA815_355.1}
2. MligTC455_23717 598 12.46 Mlig455_063516

Neo: -

Age: Down-Down-Up, logFC(26M/2M)=-0.535

Region-enriched R7: 1.983/0.01150

1.805 - - - - 0.955 0.850 Mlig455_063516 {REF} {Length: 722} {RNA1509_35160} {RNA1310_48019} {RNA815_16808}
3. MligTC455_22259 260 5.42 Mlig455_030218, Mlig455_039648

Neo: -

Age: -

CACNA2D4 1.693 - - - - 0.956 0.737

Mlig455_030218 {REF} {Length: 920} {Pfam: SAP domain [PF02037.29, score=39.1]} {RNA1509_18097} {RNA1310_23148} {RNA815_801}

Mlig455_039648 {REF} {Length: 4984} {Pfam: VWA N-terminal [PF08399.13, score=86.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=54.3]; von Willebrand factor type A domain [PF13768.8, score=35.2]; von Willebrand factor type A domain [PF00092.30, score=23.9]; von Willebrand factor type A domain [PF13519.8, score=22.7]} {Human: ENSG00000284953, CACNA2D4, calcium voltage-gated channel auxiliary subunit alpha2delta 4, [RH, Score=235, Expect=2e-65]; ENSG00000151062, CACNA2D4, calcium voltage-gated channel auxiliary subunit alpha2delta 4, [RH, Score=235, Expect=2e-65]} {Mouse: ENSMUSG00000041460, Cacna2d4, calcium channel, voltage-dependent, alpha 2/delta subunit 4, [Score=240, Expect=2e-64]; ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=233, Expect=3e-62]} {Dmel: FBgn0261041, stj, straightjacket, [RH, Score=362, Expect=1e-104]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [RH, Score=210, Expect=6e-55]} {Smed: dd_Smed_v6_8926_0_1, dd_Smed_v6_8926_0_1, [RH, Score=449, Expect=3e-135]} {RNA1509_45954} {RNA1310_7077.1} {RNA815_9934.1}
4. MligTC455_16975 57 1.18 Mlig455_058291

Neo: -

Age: -

0.991 - - - - 0.991 - Mlig455_058291 {REF} {Length: 3460} {RNA1509_57514} {RNA1310_36771} {RNA815_52846}
5. MligTC455_23716 142 2.96 Mlig455_046798

Neo: -

Age: Down-Down-Down

0.985 - - - - 0.985 - Mlig455_046798 {REF} {Length: 1088} {RNA1509_35160} {RNA1310_48019} {RNA815_16808}
6. MligTC455_20173 85 1.78 Mlig455_007486

Neo: -

Age: -

HMCN2 0.982 - - - - 0.982 - Mlig455_007486 {REF} {Length: 4297} {Pfam: Immunoglobulin domain [PF13927.8, score=196.2]; Immunoglobulin domain [PF13895.8, score=145.5]; Immunoglobulin I-set domain [PF07679.18, score=128.7]; Immunoglobulin domain [PF00047.27, score=110.7]; Immunoglobulin V-set domain [PF07686.19, score=85.1]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=46.4]; Izumo-like Immunoglobulin domain [PF16706.7, score=32.2]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=25.2]; C17orf99 Ig domain [PF17736.3, score=21.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=132, Expect=1e-30]} {Mouse: ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=134, Expect=4e-31]} {Dmel: FBgn0000547, ed, echinoid, [Score=185, Expect=2e-47]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=108, Expect=1e-23]} {Smed: dd_Smed_v6_13275_0_1, dd_Smed_v6_13275_0_1, [Score=180, Expect=3e-46]} {RNA1310_41694} {RNA815_42391}
7. MligTC455_30257 138 2.87 Mlig455_066393

Neo: -

Age: -

Region-enriched R5: 2.470/0.00815

0.973 - - - - 0.973 - Mlig455_066393 {REF} {Length: 2962} {TRANSSPLICED} {RNA1509_27782} {RNA1310_12111} {RNA815_14232}
8. MligTC455_46943 32 0.67 Mlig455_002935

Neo: -

Age: -

AVL9 0.969 - - - - 0.969 - Mlig455_002935 {REF} {Length: 4491} {Pfam: Transport protein Avl9 [PF09794.11, score=355.6]; DENN domain-containing protein 11 [PF09804.11, score=30.0]; Docking domain of Afi1 for Arf3 in vesicle trafficking [PF07792.14, score=21.9]; Stabilization of polarity axis [PF08616.12, score=20.4]} {Human: ENSG00000105778, AVL9, AVL9 cell migration associated, [RH, Score=348, Expect=5e-111]} {Mouse: ENSMUSG00000029787, Avl9, AVL9 cell migration associated, [RH, Score=345, Expect=8e-110]} {Dmel: FBgn0030499, CG11178, [Score=266, Expect=1e-79]} {Celegans: WBGene00020822, T26A5.6, [RH, Score=193, Expect=2e-54]} {Smed: dd_Smed_v6_6271_0_1, dd_Smed_v6_6271_0_1, [RH, Score=214, Expect=9e-61]} {RNA1509_17239} {RNA1310_21783} {RNA815_17887}
9. MligTC455_40596 131 2.74 Mlig455_029755, Mlig455_029759, Mlig455_029851

Neo: -

Age: -

PCDH17, PCDH9 0.968 - - - - 0.968 -

Mlig455_029755 {REF} {Length: 3844} {Pfam: Cadherin domain [PF00028.19, score=281.1]; Cadherin-like [PF08266.14, score=32.1]; Cadherin-like [PF16184.7, score=23.9]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=239, Expect=6e-64]; ENSG00000169851, PCDH7, protocadherin 7, [Score=228, Expect=1e-60]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=236, Expect=3e-63]; ENSMUSG00000029108, Pcdh7, protocadherin 7, [Score=227, Expect=1e-60]} {Dmel: FBgn0284247, ds, dachsous, [Score=227, Expect=4e-60]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_2654_0_1, dd_Smed_v6_2654_0_1, [Score=251, Expect=4e-69]} {RNA1509_47646} {RNA1310_26844} {RNA815_60336}

Mlig455_029759 {REF} {Length: 2237} {Pfam: Cadherin domain [PF00028.19, score=169.5]; Cadherin-like [PF16184.7, score=19.9]} {Human: ENSG00000118946, PCDH17, protocadherin 17, [Score=190, Expect=5e-51]; ENSG00000177839, PCDHB9, protocadherin beta 9, [Score=181, Expect=2e-48]} {Mouse: ENSMUSG00000035566, Pcdh17, protocadherin 17, [Score=189, Expect=1e-50]; ENSMUSG00000047307, Pcdhb13, protocadherin beta 13, [Score=187, Expect=1e-50]; ENSMUSG00000045689, Pcdhb4, protocadherin beta 4, [Score=185, Expect=9e-50]; ENSMUSG00000063687, Pcdhb5, protocadherin beta 5, [Score=184, Expect=2e-49]; ENSMUSG00000102222, Pcdhga10, protocadherin gamma subfamily A, 10, [Score=182, Expect=2e-48]; ENSMUSG00000045876, Pcdhb8, protocadherin beta 8, [Score=180, Expect=4e-48]} {Dmel: FBgn0284247, ds, dachsous, [Score=158, Expect=3e-40]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=126, Expect=5e-30]} {Smed: dd_Smed_v6_15376_0_1, dd_Smed_v6_15376_0_1, [Score=192, Expect=3e-52]} {RNA1509_47646} {RNA1310_26844} {RNA815_60336}

Mlig455_029851 {REF} {Length: 4327} {Pfam: Cadherin domain [PF00028.19, score=280.6]; Cadherin-like [PF08266.14, score=32.2]; Cadherin-like [PF16184.7, score=23.7]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=237, Expect=2e-63]; ENSG00000169851, PCDH7, protocadherin 7, [Score=226, Expect=3e-60]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=234, Expect=1e-63]; ENSMUSG00000029108, Pcdh7, protocadherin 7, [Score=225, Expect=5e-60]} {Dmel: FBgn0284247, ds, dachsous, [Score=226, Expect=7e-60]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=169, Expect=4e-42]} {Smed: dd_Smed_v6_11605_0_1, dd_Smed_v6_11605_0_1, [Score=250, Expect=8e-69]} {RNA1509_47646} {RNA1310_26844, RNA1509_47646} {RNA1509_47646, RNA815_60336}
10. MligTC455_11993 50 1.05 Mlig455_009030

Neo: -

Age: -

VWDE 0.965 - - - - - 0.965 Mlig455_009030 {REF} {Length: 3150} {Pfam: EGF-like domain [PF07974.15, score=63.1]; Human growth factor-like EGF [PF12661.9, score=50.6]; Agrin NtA domain [PF03146.17, score=41.8]; Thrombospondin type 1 domain [PF00090.21, score=39.6]; EGF-like domain [PF00008.29, score=33.0]; Thrombospondin type 1 domain [PF19030.2, score=23.9]} {Human: ENSG00000146530, VWDE, von Willebrand factor D and EGF domains, [RH, Score=121, Expect=9e-28]; ENSG00000156076, WIF1, WNT inhibitory factor 1, [RH, Score=119, Expect=2e-28]} {Mouse: ENSMUSG00000079679, Vwde, von Willebrand factor D and EGF domains, [RH, Score=135, Expect=2e-32]} {Dmel: FBgn0003390, shf, shifted, [RH, Score=102, Expect=7e-23]} {Celegans: WBGene00011326, T01D3.1, [Score=92.8, Expect=4e-19]} {Smed: dd_Smed_v6_20318_0_1, dd_Smed_v6_20318_0_1, [RH, Score=228, Expect=2e-65]} {RNA1509_42369} {RNA1310_21266} {RNA815_29273}
11. MligTC455_16526 125 2.61 Mlig455_026747, Mlig455_051738, Mlig455_051739, Mlig455_051760

Neo: -

Age: Up-Down-Down

GABRG3 0.965 - - - - 0.965 -

Mlig455_026747 {REF} {Length: 6317} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=31.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=25.1]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=57.8, Expect=4e-08]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=57.4, Expect=5e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=60.8, Expect=3e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=49.3, Expect=7e-06]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=517, Expect=2e-177]} {RNA1310_24908.1} {RNA815_12627}

Mlig455_051738 {REF} {Length: 1364} {RNA1310_43175} {RNA815_39065}

Mlig455_051739 {REF} {Length: 2058} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.3]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=58.9, Expect=1e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=62.8, Expect=5e-10]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=532, Expect=0.0]} {RNA1310_16047} {RNA815_12627}

Mlig455_051760 {REF} {Length: 5962} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.2]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=72.8, Expect=5e-13]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=69.7, Expect=5e-12]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=77.0, Expect=2e-14]} {Dmel: FBgn0030707, CG8916, [Score=60.5, Expect=2e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=57.8, Expect=1e-08]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [RH, Score=573, Expect=0.0]} {RNA1310_24908.1} {RNA815_12627}
12. MligTC455_11313 61 1.28 Mlig455_007918

Neo: -

Age: -

TRPC5 0.964 - - - - - 0.964 Mlig455_007918 {REF} {Length: 5108} {Pfam: Transient receptor ion channel II [PF08344.13, score=100.2]; Ion transport protein [PF00520.33, score=93.1]; Polycystin cation channel [PF08016.14, score=32.4]; Ankyrin repeats (3 copies) [PF12796.9, score=30.9]; Ankyrin repeat [PF13606.8, score=23.9]; Ankyrin repeats (many copies) [PF13637.8, score=21.3]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [Score=635, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [Score=617, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [Score=636, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [Score=617, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [Score=598, Expect=0.0]} {Celegans: WBGene00006614, trp-1, Transient-receptor-potential-like protein, [RH, Score=823, Expect=0.0]} {Smed: dd_Smed_v6_15627_0_1, dd_Smed_v6_15627_0_1, [Score=560, Expect=0.0]} {RNA1509_45595} {RNA1310_93280} {RNA815_44973}
13. MligTC455_43524 172 3.58 Mlig455_031179

Neo: -

Age: -

Region-enriched R2: 3.416/0.00534

SLC30A2 0.964 - - - - 0.964 - Mlig455_031179 {REF} {Length: 2311} {Pfam: Cation efflux family [PF01545.23, score=155.3]; Dimerisation domain of Zinc Transporter [PF16916.7, score=21.1]} {Human: ENSG00000158014, SLC30A2, solute carrier family 30 member 2, [Score=350, Expect=3e-117]} {Mouse: ENSMUSG00000028836, Slc30a2, solute carrier family 30 (zinc transporter), member 2, [Score=362, Expect=3e-122]} {Dmel: FBgn0028516, ZnT35C, Zinc transporter 35C, [RH, Score=324, Expect=1e-106]} {Celegans: WBGene00011821, cdf-2, Cation Diffusion Facilitator family, [RH, Score=324, Expect=7e-108]} {Smed: dd_Smed_v6_5529_0_1, dd_Smed_v6_5529_0_1, [Score=432, Expect=4e-150]} {RNA1509_37229} {RNA1310_13324.1} {RNA815_5520}
14. MligTC455_17175 78 1.62 Mlig455_042330, Mlig455_047110

Neo: -

Age: -

GABRA6 0.963 - - - - 0.963 -

Mlig455_042330 {REF} {Length: 1845} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=104.1]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=236, Expect=1e-72]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=229, Expect=4e-69]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=241, Expect=9e-75]} {Dmel: FBgn0030707, CG8916, [Score=248, Expect=4e-77]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=227, Expect=2e-69]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=242, Expect=6e-76]} {RNA1310_60750} {RNA815_41846}

Mlig455_047110 {REF} {Length: 1843} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=138.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.4]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=248, Expect=4e-76]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=246, Expect=4e-74]; ENSG00000151834, GABRA2, gamma-aminobutyric acid type A receptor alpha2 subunit, [Score=243, Expect=4e-74]; ENSG00000186297, GABRA5, gamma-aminobutyric acid type A receptor alpha5 subunit, [Score=242, Expect=1e-73]; ENSG00000011677, GABRA3, gamma-aminobutyric acid type A receptor alpha3 subunit, [Score=239, Expect=3e-72]; ENSG00000022355, GABRA1, gamma-aminobutyric acid type A receptor alpha1 subunit, [Score=239, Expect=2e-72]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=236, Expect=2e-71]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=254, Expect=1e-78]; ENSMUSG00000029211, Gabra4, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4, [Score=244, Expect=1e-73]; ENSMUSG00000055078, Gabra5, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5, [Score=244, Expect=1e-74]; ENSMUSG00000000560, Gabra2, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2, [Score=243, Expect=4e-74]} {Dmel: FBgn0030707, CG8916, [Score=268, Expect=2e-83]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=252, Expect=1e-77]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=263, Expect=1e-82]} {RNA1310_60750} {RNA815_41846}
15. MligTC455_28865 175 3.64 Mlig455_011624

Neo: -

Age: Down-Up-Down

EHMT1 0.962 - - - - 0.962 - Mlig455_011624 {REF} {Length: 4018} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=95.5]; Ankyrin repeats (many copies) [PF13637.8, score=86.5]; Ankyrin repeats (many copies) [PF13857.8, score=66.4]; Ankyrin repeat [PF00023.32, score=56.5]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000181090, EHMT1, euchromatic histone lysine methyltransferase 1, [Score=81.3, Expect=5e-16]; ENSG00000134313, KIDINS220, kinase D interacting substrate 220, [Score=78.6, Expect=1e-14]} {Mouse: ENSMUSG00000036893, Ehmt1, euchromatic histone methyltransferase 1, [Score=81.6, Expect=1e-15]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=68.2, Expect=1e-11]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=67.4, Expect=1e-11]} {Smed: dd_Smed_v6_10835_0_1, dd_Smed_v6_10835_0_1, [Score=70.1, Expect=2e-12]} {RNA1509_28052} {RNA1310_14237} {RNA815_22032}
16. MligTC455_27532 14 0.3 Mlig455_050096

Neo: -

Age: -

ITPKA 0.961 - - - - 0.961 - Mlig455_050096 {REF} {Length: 2853} {Pfam: Inositol polyphosphate kinase [PF03770.18, score=89.5]} {Human: ENSG00000137825, ITPKA, inositol-trisphosphate 3-kinase A, [Score=206, Expect=4e-60]; ENSG00000143772, ITPKB, inositol-trisphosphate 3-kinase B, [Score=198, Expect=2e-54]} {Mouse: ENSMUSG00000027296, Itpka, inositol 1,4,5-trisphosphate 3-kinase A, [Score=207, Expect=6e-61]; ENSMUSG00000003752, Itpkc, inositol 1,4,5-trisphosphate 3-kinase C, [Score=197, Expect=2e-55]; ENSMUSG00000038855, Itpkb, inositol 1,4,5-trisphosphate 3-kinase B, [Score=197, Expect=4e-54]} {Dmel: FBgn0032147, IP3K1, Inositol 1,4,5-triphosphate kinase 1, [Score=180, Expect=4e-52]} {Celegans: WBGene00002979, lfe-2, Inositol-trisphosphate 3-kinase homolog, [Score=207, Expect=8e-62]} {Smed: dd_Smed_v6_3687_0_2, dd_Smed_v6_3687_0_2, [Score=182, Expect=6e-51]} {RNA1509_15208} {RNA1310_45410.1} {RNA815_8803}
17. MligTC455_13094 121 2.52 Mlig455_005442, Mlig455_005513

Neo: -

Age: Up-Up-Down

0.96 - - - - 0.960 -

Mlig455_005442 {REF} {Length: 3816} {Smed: dd_Smed_v6_15433_0_1, dd_Smed_v6_15433_0_1, [Score=141, Expect=1e-34]} {RNA1509_41201} {RNA1310_51044} {RNA815_32534}

Mlig455_005513 {REF} {Length: 685} {NoTransDecoderORF} {RNA1310_56412} {RNA815_32534}
18. MligTC455_12103 45 0.93 Mlig455_058005, Mlig455_058199

Neo: -

Age: -

PTH1R 0.959 - - - - 0.959 -

Mlig455_058005 {REF} {Length: 2247} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=180.8]; Hormone receptor domain [PF02793.24, score=71.6]} {Human: ENSG00000160801, PTH1R, parathyroid hormone 1 receptor, [Score=218, Expect=5e-62]} {Mouse: ENSMUSG00000032492, Pth1r, parathyroid hormone 1 receptor, [Score=218, Expect=2e-62]} {Dmel: FBgn0033744, Dh44-R2, Diuretic hormone 44 receptor 2, [RH, Score=136, Expect=3e-34]} {Celegans: WBGene00015735, pdfr-1, Calcitonin receptor-like protein 1, [Score=108, Expect=9e-25]} {Smed: dd_Smed_v6_20871_0_1, dd_Smed_v6_20871_0_1, [Score=233, Expect=2e-69]} {RNA1310_107845}

Mlig455_058199 {REF} {Length: 2151} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=133.8]; Hormone receptor domain [PF02793.24, score=72.0]} {Human: ENSG00000160801, PTH1R, parathyroid hormone 1 receptor, [Score=180, Expect=1e-48]} {Mouse: ENSMUSG00000032492, Pth1r, parathyroid hormone 1 receptor, [Score=182, Expect=2e-49]} {Dmel: FBgn0033744, Dh44-R2, Diuretic hormone 44 receptor 2, [Score=112, Expect=5e-26]} {Celegans: WBGene00015735, pdfr-1, Calcitonin receptor-like protein 1, [Score=90.1, Expect=1e-18]} {Smed: dd_Smed_v6_20871_0_1, dd_Smed_v6_20871_0_1, [Score=206, Expect=8e-60]} {RNA1310_107845}
19. MligTC455_00165 284 5.91 Mlig455_040058

Neo: -

Age: -

0.956 - - - - 0.956 - Mlig455_040058 {REF} {Length: 541} {Smed: dd_Smed_v6_24146_0_1, dd_Smed_v6_24146_0_1, [Score=42.0, Expect=7e-06]}
20. MligTC455_33963 12 0.25 Mlig455_038335

Neo: -

Age: Up-Down-Down

0.956 - - - - 0.956 - Mlig455_038335 {REF} {Length: 3067} {Dmel: FBgn0053513, Nmdar2, NMDA receptor 2, [Score=65.1, Expect=1e-11]} {Smed: dd_Smed_v6_14850_0_1, dd_Smed_v6_14850_0_1, [Score=86.3, Expect=6e-19]} {RNA1509_41110} {RNA1310_4694.1} {RNA815_28840}
21. MligTC455_24197 48 1 Mlig455_062645

Neo: -

Age: -

KCNH7 0.955 - - - - 0.955 - Mlig455_062645 {REF} {Length: 4615} {Pfam: Ion transport protein [PF00520.33, score=125.5]; Cyclic nucleotide-binding domain [PF00027.31, score=51.0]; Ion channel [PF07885.18, score=45.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=841, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=818, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=805, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=840, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=816, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=805, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=780, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=764, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [RH, Score=841, Expect=0.0]} {RNA1509_16542} {RNA1310_43827} {RNA815_26448}
22. MligTC455_29318 93 1.93 Mlig455_068579

Neo: -

Age: logFC(26M/2M)=-0.605

SLC18A3 0.955 - - - - 0.955 - Mlig455_068579 {REF} {Length: 3048} {Pfam: Major Facilitator Superfamily [PF07690.18, score=131.7]; LacY proton/sugar symporter [PF01306.21, score=23.8]; PUCC protein [PF03209.17, score=21.8]; MFS_1 like family [PF12832.9, score=19.1]; Sugar (and other) transporter [PF00083.26, score=18.5]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [Score=393, Expect=3e-132]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [Score=395, Expect=3e-133]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [Score=434, Expect=6e-148]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [Score=392, Expect=2e-132]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [Score=452, Expect=6e-156]} {RNA1509_22907} {RNA1310_5498.1} {RNA815_3951}
23. MligTC455_36177 37 0.78 Mlig455_012519

Neo: -

Age: Up-Down-Up

FUK 0.955 - - - - 0.955 - Mlig455_012519 {REF} {Length: 3929} {TRANSSPLICED} {Pfam: GHMP kinases N terminal domain [PF00288.28, score=30.1]; L-fucokinase [PF07959.14, score=19.8]} {Human: ENSG00000157353, FUK, fucokinase, [Score=347, Expect=2e-105]} {Mouse: ENSMUSG00000033703, Fuk, fucokinase, [Score=316, Expect=3e-94]} {Celegans: WBGene00007745, C26D10.4, [RH, Score=171, Expect=3e-44]} {RNA1509_29540} {RNA1310_3161} {RNA815_21862}
24. MligTC455_42756 115 2.39 Mlig455_059859

Neo: -

Age: Up-Down-Up

FSCN1 0.955 - - - - 0.955 - Mlig455_059859 {REF} {Length: 2510} {Pfam: Fascin domain [PF06268.15, score=184.5]; FRG1-like domain [PF06229.14, score=76.5]; Ricin-type beta-trefoil lectin domain-like [PF14200.8, score=23.3]; Fibroblast growth factor [PF00167.20, score=21.4]; Domain of unknown function (DUF569) [PF04601.15, score=19.3]} {Human: ENSG00000075618, FSCN1, fascin actin-bundling protein 1, [Score=322, Expect=9e-105]; ENSG00000186765, FSCN2, fascin actin-bundling protein 2, retinal, [Score=308, Expect=3e-99]} {Mouse: ENSMUSG00000029581, Fscn1, fascin actin-bundling protein 1, [Score=317, Expect=1e-102]} {Dmel: FBgn0003447, sn, singed, [RH, Score=326, Expect=2e-106]} {Smed: dd_Smed_v6_996_0_1, dd_Smed_v6_996_0_1, [RH, Score=501, Expect=3e-175]} {RNA1509_53298} {RNA1310_18751.1, RNA1509_53298} {RNA1509_53298, RNA815_14175}
25. MligTC455_14307 7 0.14 Mlig455_010232

Neo: -

Age: -

0.954 - - - - 0.954 - Mlig455_010232 {REF} {Length: 2384} {Pfam: Endonuclease-reverse transcriptase [PF14529.8, score=55.8]; Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=20.8]; PHD-finger [PF00628.31, score=19.7]} {RNA1310_115972}
26. MligTC455_22125 178 3.71 Mlig455_028579, Mlig455_028597

Neo: -

Age: -

Region-enriched R2: 5.949/0.00261

0.954 - - - - 0.954 -

Mlig455_028579 {REF} {Length: 993} {RNA1509_54214} {RNA1310_51652} {RNA815_36975}

Mlig455_028597 {REF} {Length: 962} {RNA1509_54214} {RNA1310_51652} {RNA815_36975}
27. MligTC455_28643 2011 41.91 Mlig455_015869, Mlig455_016090

Neo: -

Age: Up-Down-Up

Region-enriched R7: 1.191/0.04546

PLG 0.954 - - - - 0.954 -

Mlig455_015869 {REF} {Length: 4911} {Pfam: MAC/Perforin domain [PF01823.21, score=60.3]; Tyrosine-protein kinase ephrin type A/B receptor-like [PF07699.15, score=55.9]; Kringle domain [PF00051.20, score=50.9]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=20.5]} {Human: ENSG00000122194, PLG, plasminogen, [Score=73.2, Expect=3e-12]} {Mouse: ENSMUSG00000059481, Plg, plasminogen, [Score=82.8, Expect=2e-15]} {Celegans: WBGene00018547, clec-78, C-type LECtin, [Score=58.9, Expect=4e-08]} {Smed: dd_Smed_v6_3432_0_1, dd_Smed_v6_3432_0_1, [Score=65.1, Expect=7e-11]} {RNA1509_2909} {RNA1310_931} {RNA815_5465}

Mlig455_016090 {REF} {Length: 5592} {Pfam: Tyrosine-protein kinase ephrin type A/B receptor-like [PF07699.15, score=162.1]; MAC/Perforin domain [PF01823.21, score=60.0]; Kringle domain [PF00051.20, score=50.3]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=45.3]} {Human: ENSG00000122194, PLG, plasminogen, [Score=72.8, Expect=5e-12]} {Mouse: ENSMUSG00000109446, Gm9195, predicted gene 9195, [Score=82.4, Expect=5e-15]; ENSMUSG00000059481, Plg, plasminogen, [Score=82.0, Expect=4e-15]} {Dmel: FBgn0031879, uif, uninflatable, [Score=78.2, Expect=6e-14]} {Celegans: WBGene00018547, clec-78, C-type LECtin, [Score=70.9, Expect=9e-12]} {Smed: dd_Smed_v6_3432_0_1, dd_Smed_v6_3432_0_1, [Score=110, Expect=6e-26]} {RNA1509_2909} {RNA1310_931, RNA1509_2909} {RNA1509_2909, RNA815_283}
28. MligTC455_38967 71 1.48 Mlig455_060741

Neo: -

Age: Up-Down-Down, logFC(26M/2M)=-0.569

Region-enriched R2: 3.815/0.00926
Region-enriched R7: 3.563/0.01797

UTRN 0.953 - - - - 0.953 - Mlig455_060741 {REF} {Length: 4727} {Pfam: EF-hand [PF09069.13, score=127.4]; EF hand [PF09068.13, score=102.4]; Zinc finger, ZZ type [PF00569.19, score=37.7]; WW domain [PF00397.28, score=18.6]} {Human: ENSG00000152818, UTRN, utrophin, [RH, Score=493, Expect=5e-147]; ENSG00000198947, DMD, dystrophin, [RH, Score=489, Expect=1e-150]} {Mouse: ENSMUSG00000019820, Utrn, utrophin, [RH, Score=493, Expect=2e-156]; ENSMUSG00000045103, Dmd, dystrophin, muscular dystrophy, [RH, Score=487, Expect=3e-145]} {Dmel: FBgn0260003, Dys, Dystrophin, [RH, Score=516, Expect=4e-155]} {Celegans: WBGene00001131, dys-1, Dystrophin-1, [RH, Score=337, Expect=1e-95]} {Smed: dd_Smed_v6_5325_0_6, dd_Smed_v6_5325_0_6, [RH, Score=295, Expect=4e-82]} {RNA1509_38827} {RNA1310_24533} {RNA815_12379}
29. MligTC455_16844 22 0.47 Mlig455_032383

Neo: -

Age: -

NPY1R 0.952 - - - - 0.952 - Mlig455_032383 {REF} {Length: 1642} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=126.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.7]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=111, Expect=2e-26]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=110, Expect=3e-26]; ENSMUSG00000048337, Npy4r, neuropeptide Y receptor Y4, [Score=108, Expect=1e-25]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=152, Expect=8e-41]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=135, Expect=4e-35]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=216, Expect=3e-65]} {RNA1310_56955}
30. MligTC455_17021 49 1.02 Mlig455_030263

Neo: -

Age: -

0.952 - - - - 0.952 - Mlig455_030263 {REF} {Length: 566} {TRANSSPLICED} {Pfam: Galactosyltransferase [PF01762.23, score=23.7]} {Dmel: FBgn0000221, brn, brainiac, [Score=45.8, Expect=1e-06]} {RNA1310_35735} {RNA815_59866}
31. MligTC455_32501 34 0.71 Mlig455_053552

Neo: -

Age: -

Region-enriched R2: 9.313/0.01306
Region-enriched R6: 7.517/0.01711

GRIA1 0.952 - - - - 0.952 - Mlig455_053552 {REF} {Length: 4329} {Pfam: Ligand-gated ion channel [PF00060.28, score=197.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=125.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=87.5]; Receptor family ligand binding region [PF01094.30, score=76.3]} {Human: ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [RH, Score=605, Expect=0.0]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [RH, Score=577, Expect=0.0]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [RH, Score=577, Expect=0.0]} {Mouse: ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [RH, Score=603, Expect=0.0]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [RH, Score=582, Expect=0.0]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [RH, Score=576, Expect=0.0]} {Dmel: FBgn0004619, GluRIA, Glutamate receptor IA, [RH, Score=499, Expect=6e-161]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [RH, Score=504, Expect=2e-163]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [RH, Score=740, Expect=0.0]} {RNA1509_47919} {RNA1310_3776} {RNA815_11355.1}
32. MligTC455_33394 29 0.6 Mlig455_020353, Mlig455_041292

Neo: -

Age: -

RASGRP1, RASGRP3 0.952 - - - - 0.952 -

Mlig455_020353 {REF} {Length: 2230} {Pfam: RasGEF domain [PF00617.21, score=61.8]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=51.4]; EF hand [PF00036.34, score=33.2]; EF-hand domain [PF13405.8, score=32.5]; EF-hand domain pair [PF13499.8, score=28.5]; EF hand [PF13202.8, score=28.0]} {Human: ENSG00000152689, RASGRP3, RAS guanyl releasing protein 3, [Score=360, Expect=2e-115]; ENSG00000172575, RASGRP1, RAS guanyl releasing protein 1, [Score=349, Expect=6e-110]} {Mouse: ENSMUSG00000071042, Rasgrp3, RAS, guanyl releasing protein 3, [Score=356, Expect=2e-114]} {Dmel: FBgn0003093, Pkc98E, Protein C kinase 98E, [Score=65.1, Expect=9e-11]} {Celegans: WBGene00009100, rgef-1, Rap Guanine nucleotide Exchange Factor homolog, [Score=302, Expect=3e-94]} {Smed: dd_Smed_v6_15742_0_2, dd_Smed_v6_15742_0_2, [Score=270, Expect=3e-85]} {RNA1310_83329}

Mlig455_041292 {REF} {Length: 3588} {Pfam: RasGEF domain [PF00617.21, score=145.2]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=52.4]; EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.3]; EF-hand domain pair [PF13499.8, score=30.9]; EF hand [PF13202.8, score=29.5]; EF-hand domain pair [PF13833.8, score=19.2]} {Human: ENSG00000172575, RASGRP1, RAS guanyl releasing protein 1, [RH, Score=451, Expect=8e-148]} {Mouse: ENSMUSG00000071042, Rasgrp3, RAS, guanyl releasing protein 3, [RH, Score=453, Expect=2e-150]; ENSMUSG00000027347, Rasgrp1, RAS guanyl releasing protein 1, [RH, Score=438, Expect=3e-143]} {Dmel: FBgn0034158, CG5522, [Score=95.9, Expect=3e-20]} {Celegans: WBGene00009100, rgef-1, Rap Guanine nucleotide Exchange Factor homolog, [Score=416, Expect=2e-136]} {Smed: dd_Smed_v6_15742_0_2, dd_Smed_v6_15742_0_2, [RH, Score=288, Expect=3e-91]} {RNA1509_53196} {RNA1310_34349} {RNA815_31634}
33. MligTC455_00075 9 0.18 Mlig455_038379

Neo: -

Age: -

0.951 - - - - 0.951 - Mlig455_038379 {REF} {Length: 353} {NoTransDecoderORF}
34. MligTC455_02095 6 0.13 Mlig455_050251

Neo: -

Age: -

0.951 - - - - 0.951 - Mlig455_050251 {REF} {Length: 1026} {Pfam: Protein of unknown function (DUF445) [PF04286.14, score=25.2]}
35. MligTC455_02167 3 0.07 Mlig455_055463

Neo: -

Age: -

0.951 - - - - 0.951 - Mlig455_055463 {REF} {Length: 1418} {RNA1509_23358} {RNA1310_93521} {RNA815_55072.1}
36. MligTC455_13244 13 0.27 Mlig455_000768

Neo: -

Age: -

0.951 - - - - 0.951 - Mlig455_000768 {REF} {Length: 2047} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=109.0]} {Smed: dd_Smed_v6_15195_0_1, dd_Smed_v6_15195_0_1, [Score=50.4, Expect=2e-06]} {RNA1310_70552} {RNA815_45450}
37. MligTC455_23406 12 0.25 Mlig455_000831

Neo: -

Age: -

DGKI 0.951 - - - - 0.951 - Mlig455_000831 {REF} {Length: 2690} {Pfam: Diacylglycerol kinase accessory domain [PF00609.21, score=144.4]; Diacylglycerol kinase catalytic domain [PF00781.26, score=81.7]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=32.0]} {Human: ENSG00000157680, DGKI, diacylglycerol kinase iota, [Score=546, Expect=0.0]; ENSG00000149091, DGKZ, diacylglycerol kinase zeta, [Score=534, Expect=2e-178]} {Mouse: ENSMUSG00000038665, Dgki, diacylglycerol kinase, iota, [Score=548, Expect=0.0]; ENSMUSG00000040479, Dgkz, diacylglycerol kinase zeta, [Score=535, Expect=6e-179]} {Dmel: FBgn0261549, rdgA, retinal degeneration A, [Score=436, Expect=2e-140]} {Celegans: WBGene00019428, dgk-5, Putative diacylglycerol kinase K06A1.6, [Score=457, Expect=6e-149]} {Smed: dd_Smed_v6_12579_0_2, dd_Smed_v6_12579_0_2, [Score=503, Expect=3e-166]} {RNA1509_47663} {RNA1310_38777} {RNA815_25929}
38. MligTC455_38667 17 0.35 Mlig455_059621

Neo: -

Age: -

0.951 - - - - 0.951 - Mlig455_059621 {REF} {Length: 1297} {RNA1310_51041}
39. MligTC455_44845 96 2 Mlig455_063520

Neo: -

Age: -

LHX5 0.951 - - - - 0.951 - Mlig455_063520 {REF} {Length: 4042} {Pfam: LIM domain [PF00412.24, score=116.9]; Homeodomain [PF00046.31, score=69.5]; Homeobox KN domain [PF05920.13, score=24.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=19.8]} {Human: ENSG00000089116, LHX5, LIM homeobox 5, [Score=208, Expect=9e-59]; ENSG00000273706, LHX1, LIM homeobox 1, [Score=199, Expect=1e-55]; ENSG00000274577, LHX1, LIM homeobox 1, [Score=199, Expect=1e-55]} {Mouse: ENSMUSG00000029595, Lhx5, LIM homeobox protein 5, [Score=207, Expect=1e-58]; ENSMUSG00000018698, Lhx1, LIM homeobox protein 1, [Score=199, Expect=1e-55]} {Dmel: FBgn0026411, Lim1, LIM homeobox 1, [Score=191, Expect=3e-52]} {Celegans: WBGene00003000, lin-11, [Score=141, Expect=6e-36]} {Smed: dd_Smed_v6_11521_0_1, dd_Smed_v6_11521_0_1, [RH, Score=185, Expect=5e-49]} {RNA1509_55597} {RNA1310_42478} {RNA815_25756}
40. MligTC455_45569 10 0.2 Mlig455_050997

Neo: -

Age: -

NPFFR2 0.951 - - - - 0.951 - Mlig455_050997 {REF} {Length: 1679} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=95.0]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=74.7, Expect=9e-14]; ENSG00000102239, BRS3, bombesin receptor subtype 3, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000031130, Brs3, bombesin-like receptor 3, [Score=72.0, Expect=4e-13]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=69.3, Expect=2e-12]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=68.6, Expect=5e-12]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=68.6, Expect=4e-12]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [Score=84.7, Expect=3e-17]} {Celegans: WBGene00006576, tkr-1, Probable G-protein coupled receptor tkr-1, [Score=65.9, Expect=2e-11]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=76.6, Expect=6e-15]}
41. MligTC455_55036 4 0.08 Mlig455_068959

Neo: -

Age: -

0.951 - - - - 0.951 - Mlig455_068959 {REF} {Length: 361}
42. MligTC455_55202 6 0.13 Mlig455_009943

Neo: -

Age: -

0.951 - - - - 0.951 - Mlig455_009943 {REF} {Length: 1032}
43. MligTC455_55726 9 0.19 Mlig455_002317

Neo: -

Age: -

0.951 - - - - 0.951 - Mlig455_002317 {REF} {Length: 697} {NoTransDecoderORF} {RNA1509_46046} {RNA1310_45776} {RNA815_35011}
44. MligTC455_56175 4 0.09 Mlig455_047305

Neo: -

Age: -

0.951 - - - - 0.951 - Mlig455_047305 {REF} {Length: 151} {NoTransDecoderORF} {RNA1310_40540} {RNA815_49298}
45. MligTC455_17876 16 0.34 Mlig455_065373

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=1.265

0.95 - - - - 0.950 - Mlig455_065373 {REF} {Length: 1842} {Pfam: Lipase (class 3) [PF01764.27, score=95.4]} {Celegans: WBGene00022457, Y110A7A.7, [RH, Score=147, Expect=3e-41]} {RNA1509_14474} {RNA1310_18576.2} {RNA815_8106.1}
46. MligTC455_19850 21 0.44 Mlig455_016817

Neo: -

Age: Down-Down-Down, logFC(26M/2M)=-1.038

GUCY1B1 0.95 - - - - 0.950 - Mlig455_016817 {REF} {Length: 2782} {Pfam: Heme NO binding associated [PF07701.16, score=218.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=199.9]; Haem-NO-binding [PF07700.17, score=175.1]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=338, Expect=4e-107]} {Mouse: ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=342, Expect=6e-109]; ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=339, Expect=1e-105]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=593, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=513, Expect=2e-174]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=823, Expect=0.0]} {RNA1509_55074} {RNA1310_24262} {RNA815_41754}
47. MligTC455_33814 559 11.65 Mlig455_061944

Neo: -

Age: Down-Up-Down

Region-enriched R2: 5.446/0.00053
Region-enriched R8: 3.618/0.02514

MOXD1 0.95 - - - - 0.950 - Mlig455_061944 {REF} {Length: 2816} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=105.5]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=67.8]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=129, Expect=2e-31]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=141, Expect=1e-35]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=116, Expect=3e-27]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=129, Expect=9e-32]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=120, Expect=7e-30]} {RNA1509_41983} {RNA1310_8990, RNA1509_41983} {RNA1509_41983, RNA815_3230}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA